Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen

Proceedings of the National Academy of Sciences of the United States of America

Volumn 88, Issue 1, 1991, Pages 110-114

  Chen, L ^a   Thomas, E K ^a   Hu, S L ^a   Hellstrom, I ^a   Hellstrom, K E ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

immunoprevention; immunosurveillance; immunotherapy; tumor immunity

Indexed keywords

NUCLEOPROTEIN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; IMMUNOSURVEILLANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; WART VIRUS;

ANIMAL; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; FEMALE; GENES, VIRAL; GENETIC VECTORS; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE DEPLETION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS; PLASMIDS; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; TRANSFECTION;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0026074396     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.88.1.110     Document Type: Article

References (0)